Found 5 matching trials
A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab
PHASE1Protocol VRXP-A106 will enroll patients with Stage II-IVA head and neck can...
Location
University of Pittsburgh Medical Center
A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer
PHASE1This is an open label, Phase 1b pre-operative window of opportunity biomark...
Location
Local Institution - 112
Intratumoral Microdosing of Motolimod in HNSCC
EARLY_PHASE1This is a multi-center, single arm, open-label, multi-agent, localized phar...
Location
University of California, San Francisco
Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer
PHASE1This is an ongoing Phase 1/2, open-label, multicenter, non-randomized study...
Location
Research Facitlity
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
PHASE1This phase Ib trial studies the best way of TLR8 Agonist VTX-2337 and cyclo...
Location
Mayo Clinic in Arizona